Publications
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | First Faculty of Medicine
- Treatment of anaemia with erythropoiesis-stimulating proteins in patients with myelodysplastic syndrome2010 | First Faculty of Medicine
- Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome2009 | First Faculty of Medicine
- Molecular cytogenetic studies of complex karyotypes in myelodysplastic syndromes (MDS): conventional cytogenetics, FISH and multiplex FISH (mFISH/mBAND)Publication without faculty affiliation
- True monozomy of chromosome 5 is presumably not an isolated cytogenetic entity in myelodysplastic syndromes (MDS).Publication without faculty affiliation
- The response of FLi1, EKLF, TP53 (p53), PU.1, MDM2 gene expression in 5q- syndrome to lenalidomide treatmentPublication without faculty affiliation
- Retrospective study of deletions of 5q in patients with myelodysplastic syndrome (MDS) or acute maeloid leukemia (AML)Publication without faculty affiliation
- Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution2020 | First Faculty of Medicine
- Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients)2018 | First Faculty of Medicine
- Komentář ke studii (Léčba esenciální trombocytemie v Evropě - studie EXELS s anagrelidem)2018 | First Faculty of Medicine
Loading network view...